Leanne Barnard

Leanne Barnard

Auto-generated profile, based on publicly available information

Leanne Barnard

Department of Biochemistry, Stellenbosch University, Stellenbosch 7600, South Africa

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ETErick T Tjhin
Erick T Tjhin
CSChristina Spry
Christina Spry
ASAlan L Sewell
Alan L Sewell
AHAnnabelle Hoegl
Annabelle Hoegl
LBLeanne Barnard
Leanne Barnard
KSKevin J. Saliba
Kevin J. Saliba
The malaria-causing blood stage of Plasmodium falciparum requires extracellular pantothenate for proliferation. The parasite converts pantothenate into coenzyme A (CoA) via five enzymes, the first being a pantothenate kinase (PfPanK). Multiple antiplasmodial pantothenate analogues, including pantothenol and CJ-15,801, kill the parasite by targeting CoA biosynthesis/utilisation. Their mechanism of action, however, remains unknown. Here, we show that parasites pressured with pantothenol or CJ-15,801 become resistant to these analogues. Whole-genome sequencing revealed mutations in one of two putative PanK genes (Pfpank1) in each resistant line. These mutations significantly alter PfPanK activity, with two conferring a fitness cost, consistent with Pfpank1 coding for a functional PanK that is essential for normal growth. The mutants exhibit a different sensitivity profile to recently-described, potent, antiplasmodial pantothenate analogues, with one line being hypersensitive. We provide evidence consistent with different pantothenate analogue classes having different mechanisms of action: some inhibit CoA biosynthesis while others inhibit CoA-utilising enzymes. The coenzyme A (CoA) biosynthetic pathway is under investigation as a target for the development of drugs aimed at several infectious agents, including malaria parasites. To synthesise CoA, the parasite scavenges the essential precursor pantothenate (vitamin B5). Several pantothenate analogues possess potent (nM) activity against the parasite, but their exact mechanism of action is unknown. We have generated mutant parasites that are resistant or hypersensitive to various pantothenate analogues. These parasites harbour mutations in a gene we now show codes for the first enzyme in the CoA biosynthesis pathway. This enzyme is not the target of the analogues, but instead converts them into antimetabolites that, depending on the analogue, either inhibit a CoA biosynthesis enzyme or downstream CoA-utilising enzymes.

1 June 2015 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
CMCristiano J. Macuamule
Cristiano J. Macuamule
ETErick T. Tjhin
Erick T. Tjhin
CJCollins E. Jana
Collins E. Jana
LBLeanne Barnard
Leanne Barnard
LKLizbé Koekemoer
Lizbé Koekemoer
ESErick Strauss
Erick Strauss
Pantothenamides inhibit blood-stage Plasmodium falciparum with potencies (50% inhibitory concentration [IC 50 ], ∼20 nM) similar to that of chloroquine. They target processes dependent on pantothenate, a precursor of the essential metabolic cofactor coenzyme A. However, their antiplasmodial activity is reduced due to degradation by serum pantetheinase. Minor modification of the pantothenamide structure led to the identification of α-methyl- N -phenethyl-pantothenamide, a pantothenamide resistant to degradation, with excellent antiplasmodial activity (IC 50 , 52 ± 6 nM), target specificity, and low toxicity.


4 May 2017 in ACS Infectious Diseases
Verified
Journal Article
Closed access
MVMarianne de Villiers
Marianne de Villiers
CSChristina Spry
Christina Spry
CMCristiano J. Macuamule
Cristiano J. Macuamule
LBLeanne Barnard
Leanne Barnard
GWGordon Wells
Gordon Wells
ESErick Strauss
Erick Strauss

1 December 2017 in Animal Feed Science and Technology
Verified
Journal Article
Open access
YDYueming Dersjant-Li
Yueming Dersjant-Li
AWAlexandra Wealleans
Alexandra Wealleans
LBL.P. Barnard
L.P. Barnard
SLS. Lane
S. Lane

14 January 2018 in ACS Infectious Diseases
Verified
Journal Article
Closed access
LBLeanne Barnard
Leanne Barnard
KMKonrad Johannes Mostert
Konrad Johannes Mostert
WOWillem A. L. van Otterlo
Willem A. L. van Otterlo
ESErick Strauss
Erick Strauss